Effects of the testosterone metabolite dihydrotestosterone and 5α-androstan-3α,17β-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts

A. Petroni, M. Blasevich, G. Uziel

Research output: Contribution to journalArticle

Abstract

X-Adrenoleukodystrophy (X-ALD) is a peroxisomal disorder associated with the abnormal accumulation of very long chain fatty acids (VLCFA) in plasma and tissues. We have demonstrated that the androgen dihydrotestosterone (DHT) and 5α-androstan-3α,17β-diol (3α-diol) have favorable effect on VLCFA metabolism. We have investigated the effect of androgens on peroxisomal β-oxidation, the incorporation of labelled lignoceric acid into cholesterol esters and VLCFA elongation, in cultured skin-fibroblasts from control and X-ALD patients. The androgens significantly increased peroxisomal β-oxidation in X-ALD fibroblasts although VLCFA levels were not normalized. The major effect was on the incorporation of labelled lignoceric acid into cholesterol esters, since the enhanced lignoceric acid incorporation into cholesterol ester fraction, which occurred in X-ALD fibroblasts, was reduced towards normal values. In contrast, the androgens had no effect on the elongation pathway.

Original languageEnglish
Pages (from-to)1567-1575
Number of pages9
JournalLife Sciences
Volume73
Issue number12
DOIs
Publication statusPublished - Aug 8 2003

Fingerprint

Adrenoleukodystrophy
Dihydrotestosterone
Fibroblasts
Metabolites
Metabolism
Androgens
Testosterone
Cholesterol Esters
Fatty Acids
Elongation
Peroxisomal Disorders
Oxidation
Skin
Reference Values
Tissue
Plasmas
lignoceric acid

Keywords

  • Cholesterol ester
  • Peroxisomal β-oxidation
  • Testosterone metabolites
  • Very long chain fatty acids
  • X-Adrenoleukodystrophy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of the testosterone metabolite dihydrotestosterone and 5α-androstan-3α,17β-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts. / Petroni, A.; Blasevich, M.; Uziel, G.

In: Life Sciences, Vol. 73, No. 12, 08.08.2003, p. 1567-1575.

Research output: Contribution to journalArticle

@article{fa7baf8303fa431fbcd7d8ebfb7d2408,
title = "Effects of the testosterone metabolite dihydrotestosterone and 5α-androstan-3α,17β-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts",
abstract = "X-Adrenoleukodystrophy (X-ALD) is a peroxisomal disorder associated with the abnormal accumulation of very long chain fatty acids (VLCFA) in plasma and tissues. We have demonstrated that the androgen dihydrotestosterone (DHT) and 5α-androstan-3α,17β-diol (3α-diol) have favorable effect on VLCFA metabolism. We have investigated the effect of androgens on peroxisomal β-oxidation, the incorporation of labelled lignoceric acid into cholesterol esters and VLCFA elongation, in cultured skin-fibroblasts from control and X-ALD patients. The androgens significantly increased peroxisomal β-oxidation in X-ALD fibroblasts although VLCFA levels were not normalized. The major effect was on the incorporation of labelled lignoceric acid into cholesterol esters, since the enhanced lignoceric acid incorporation into cholesterol ester fraction, which occurred in X-ALD fibroblasts, was reduced towards normal values. In contrast, the androgens had no effect on the elongation pathway.",
keywords = "Cholesterol ester, Peroxisomal β-oxidation, Testosterone metabolites, Very long chain fatty acids, X-Adrenoleukodystrophy",
author = "A. Petroni and M. Blasevich and G. Uziel",
year = "2003",
month = "8",
day = "8",
doi = "10.1016/S0024-3205(03)00474-0",
language = "English",
volume = "73",
pages = "1567--1575",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Effects of the testosterone metabolite dihydrotestosterone and 5α-androstan-3α,17β-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts

AU - Petroni, A.

AU - Blasevich, M.

AU - Uziel, G.

PY - 2003/8/8

Y1 - 2003/8/8

N2 - X-Adrenoleukodystrophy (X-ALD) is a peroxisomal disorder associated with the abnormal accumulation of very long chain fatty acids (VLCFA) in plasma and tissues. We have demonstrated that the androgen dihydrotestosterone (DHT) and 5α-androstan-3α,17β-diol (3α-diol) have favorable effect on VLCFA metabolism. We have investigated the effect of androgens on peroxisomal β-oxidation, the incorporation of labelled lignoceric acid into cholesterol esters and VLCFA elongation, in cultured skin-fibroblasts from control and X-ALD patients. The androgens significantly increased peroxisomal β-oxidation in X-ALD fibroblasts although VLCFA levels were not normalized. The major effect was on the incorporation of labelled lignoceric acid into cholesterol esters, since the enhanced lignoceric acid incorporation into cholesterol ester fraction, which occurred in X-ALD fibroblasts, was reduced towards normal values. In contrast, the androgens had no effect on the elongation pathway.

AB - X-Adrenoleukodystrophy (X-ALD) is a peroxisomal disorder associated with the abnormal accumulation of very long chain fatty acids (VLCFA) in plasma and tissues. We have demonstrated that the androgen dihydrotestosterone (DHT) and 5α-androstan-3α,17β-diol (3α-diol) have favorable effect on VLCFA metabolism. We have investigated the effect of androgens on peroxisomal β-oxidation, the incorporation of labelled lignoceric acid into cholesterol esters and VLCFA elongation, in cultured skin-fibroblasts from control and X-ALD patients. The androgens significantly increased peroxisomal β-oxidation in X-ALD fibroblasts although VLCFA levels were not normalized. The major effect was on the incorporation of labelled lignoceric acid into cholesterol esters, since the enhanced lignoceric acid incorporation into cholesterol ester fraction, which occurred in X-ALD fibroblasts, was reduced towards normal values. In contrast, the androgens had no effect on the elongation pathway.

KW - Cholesterol ester

KW - Peroxisomal β-oxidation

KW - Testosterone metabolites

KW - Very long chain fatty acids

KW - X-Adrenoleukodystrophy

UR - http://www.scopus.com/inward/record.url?scp=0037627833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037627833&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(03)00474-0

DO - 10.1016/S0024-3205(03)00474-0

M3 - Article

C2 - 12865096

AN - SCOPUS:0037627833

VL - 73

SP - 1567

EP - 1575

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 12

ER -